| __timestamp | ACADIA Pharmaceuticals Inc. | Gilead Sciences, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 3788000000 |
| Thursday, January 1, 2015 | 76369000 | 4006000000 |
| Friday, January 1, 2016 | 4406000 | 4261000000 |
| Sunday, January 1, 2017 | 13060000 | 4371000000 |
| Monday, January 1, 2018 | 18330000 | 4853000000 |
| Tuesday, January 1, 2019 | 19598000 | 4675000000 |
| Wednesday, January 1, 2020 | 20550000 | 4572000000 |
| Friday, January 1, 2021 | 19141000 | 6601000000 |
| Saturday, January 1, 2022 | 10166000 | 5657000000 |
| Sunday, January 1, 2023 | 45731000 | 6498000000 |
| Monday, January 1, 2024 | 28675800000 |
Cracking the code
In the ever-evolving landscape of biotechnology, understanding the cost of revenue is crucial for assessing a company's financial health. This chart offers a fascinating comparison between Gilead Sciences, Inc. and ACADIA Pharmaceuticals Inc. over the past decade, from 2014 to 2023.
Gilead Sciences, a titan in the industry, consistently reported a cost of revenue that dwarfs that of ACADIA, with figures peaking at approximately $6.6 billion in 2021. This represents a staggering 1,300% increase compared to ACADIA's highest cost of revenue in 2015. Meanwhile, ACADIA's cost of revenue fluctuated, reaching its zenith in 2015 and experiencing a notable dip in 2016.
This data underscores the scale at which Gilead operates, reflecting its expansive product portfolio and market reach. In contrast, ACADIA's more modest figures highlight its focused approach in the biotech sector.
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Gilead Sciences, Inc.
Analyzing Cost of Revenue: Gilead Sciences, Inc. and Ionis Pharmaceuticals, Inc.
Gilead Sciences, Inc. vs Amneal Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Gilead Sciences, Inc. vs Mesoblast Limited
Cost Insights: Breaking Down Incyte Corporation and ACADIA Pharmaceuticals Inc.'s Expenses
BioMarin Pharmaceutical Inc. vs ACADIA Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Sarepta Therapeutics, Inc. and ACADIA Pharmaceuticals Inc.
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs ACADIA Pharmaceuticals Inc.
Cost of Revenue Comparison: Halozyme Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.
Cost of Revenue Trends: Grifols, S.A. vs ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc. vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: ACADIA Pharmaceuticals Inc. vs Evotec SE